ClinicalTrials.gov
ClinicalTrials.gov Menu

BiPAP for Cardiomyopathy With Central Sleep Apnea

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00282789
Recruitment Status : Completed
First Posted : January 27, 2006
Last Update Posted : January 30, 2006
Sponsor:
Information provided by:
Nagoya University

Brief Summary:
We investigated whether treatment of central sleep apnea-hypopnea with bilevel positive airway pressure (BiPAP) in patients with idiopathic dilated cardiomyopathy (IDCM) would improve LV function.

Condition or disease Intervention/treatment Phase
Dilated Cardiomyopathy Device: bilevel positive airway pressure Device: bilevel positive airway pressure (Device) Not Applicable

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : June 2000






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Idiopathic dilated cardiomyopathy

Exclusion Criteria:

  • a history of alcohol abuse, diabetes mellitus, endocrine disorders, hypertension, obstructive sleep apnea syndrome, and chronic obstructive pulmonary disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00282789


Locations
Japan
Nagoya University of Health Sciences
Nagoya, Japan, 461-8673
Sponsors and Collaborators
Nagoya University
Investigators
Study Chair: Mitsuhiro Yokota, MD,PhD Department of Cardiovascular Genome Science, Nagoya University School of Medicine, Nagoya, Aichi, Japan

ClinicalTrials.gov Identifier: NCT00282789     History of Changes
Other Study ID Numbers: NU-06-A-0002
First Posted: January 27, 2006    Key Record Dates
Last Update Posted: January 30, 2006
Last Verified: June 2000

Additional relevant MeSH terms:
Cardiomyopathies
Cardiomyopathy, Dilated
Heart Diseases
Cardiovascular Diseases
Cardiomegaly